Thioridazine Hcl



Indications and Reactions:

Role Indications Reactions
Primary
Tuberculosis 65.8%
Drug Use For Unknown Indication 7.9%
Depression 5.3%
Psychotic Disorder 5.3%
Bipolar Disorder 2.6%
Insomnia 2.6%
Mental Disorder 2.6%
Schizoaffective Disorder 2.6%
Schizoaffective Disorder Bipolar Type 2.6%
Schizophrenia 2.6%
Cardio-respiratory Arrest 11.5%
Epilepsy 11.5%
Optic Neuritis 7.7%
Transaminases Increased 7.7%
Blindness 3.8%
Coma 3.8%
Death 3.8%
Hepatic Enzyme Increased 3.8%
Maternal Drugs Affecting Foetus 3.8%
Medication Error 3.8%
Neuropathy Peripheral 3.8%
Paraesthesia 3.8%
Parkinsonism 3.8%
Respiratory Rate Increased 3.8%
Tardive Dyskinesia 3.8%
Thrombocytopenia 3.8%
Tourette's Disorder 3.8%
Treatment Noncompliance 3.8%
Unevaluable Event 3.8%
Vanishing Bile Duct Syndrome 3.8%
Secondary
Product Used For Unknown Indication 31.4%
Tuberculosis 31.0%
Drug Use For Unknown Indication 12.5%
Schizophrenia, Paranoid Type 3.3%
Schizophrenia 2.6%
Delusion 2.2%
Anxiety 1.8%
Hypochondriasis 1.8%
Psychiatric Symptom 1.8%
Amnestic Disorder 1.5%
Bipolar Disorder 1.5%
Bronchitis 1.5%
Dementia Alzheimer's Type 1.5%
Acute Psychosis 1.1%
Angina Pectoris 0.7%
Convulsion 0.7%
Diuretic Therapy 0.7%
Gastrooesophageal Reflux Disease 0.7%
Meniere's Disease 0.7%
Pain 0.7%
Pancytopenia 13.8%
Polyneuropathy 13.8%
Anaemia 6.9%
Renal Failure Acute 6.9%
Respiratory Arrest 6.9%
Acute Hepatic Failure 5.2%
Neuroleptic Malignant Syndrome 5.2%
Tremor 5.2%
Vomiting 5.2%
Cardio-respiratory Arrest 3.4%
Hypotension 3.4%
Myocardial Infarction 3.4%
Somnolence 3.4%
Suicide Attempt 3.4%
Thrombocytopenia 3.4%
Treatment Noncompliance 3.4%
Acute Myeloid Leukaemia 1.7%
Blood Creatine Phosphokinase Increased 1.7%
Cognitive Disorder 1.7%
Completed Suicide 1.7%
Concomitant
Drug Use For Unknown Indication 20.3%
Product Used For Unknown Indication 12.7%
Depression 10.0%
Schizophrenia 9.3%
Anxiety 7.2%
Pain 5.2%
Constipation 4.5%
Sleep Disorder 4.5%
Psychotic Disorder 3.1%
Bipolar Disorder 2.7%
Hypothyroidism 2.7%
Intervertebral Disc Degeneration 2.7%
Gastrooesophageal Reflux Disease 2.4%
Malignant Melanoma 2.4%
Hyperlipidaemia 2.1%
Nausea 2.1%
Insomnia 1.7%
Vitamin Supplementation 1.7%
Affective Disorder 1.4%
Anticoagulant Therapy 1.4%
Suicidal Ideation 16.7%
Type 2 Diabetes Mellitus 8.3%
Vomiting 8.3%
Weight Increased 8.3%
Withdrawal Syndrome 8.3%
Vaginal Infection 6.0%
Agitation 4.8%
Premature Baby 4.8%
Cardiac Death 3.6%
Drug Ineffective 3.6%
Granulocytopenia 3.6%
Tearfulness 3.6%
Trigeminal Neuralgia 3.6%
Aggression 2.4%
Convulsion 2.4%
Depression 2.4%
Drug Interaction 2.4%
Drug Withdrawal Syndrome 2.4%
Fatigue 2.4%
General Physical Health Deterioration 2.4%
Interacting
Product Used For Unknown Indication 100.0%
Drug Interaction 100.0%